A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation. - Wikidata - awgldk - TriplyDB

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation.

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation.

http://www.wikidata.org/entity/Q38854836

about

Evaluation of Time in Therapeutic Range (TTR) in Patients with Non-Valvular Atrial Fibrillation Receiving Treatment with Warfarin in Tehran, Iran: A Cross-Sectional Study.The Health Buddies App as a Novel Tool to Improve Adherence and Knowledge in Atrial Fibrillation Patients: A Pilot Study Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation.The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation.Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study.Comparison of claims vs patient-reported adherence measures and associated outcomes among patients with nonvalvular atrial fibrillation using oral anticoagulant therapy.Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation.NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands.

P2860

Q37352988-790CB883-66CB-46AF-A256-3506565DA9FF Q38654986-9063F755-230C-4C37-B774-B1B48E90BDB3 Q38662571-38D32A8C-B8C8-4B06-AAC8-D63125BC2874 Q48132702-275E789B-C8B5-48E8-9096-84DA4F9C47C7 Q48233579-DC206879-1DC4-42DC-BA15-F75483340A55 Q49189568-49AE0547-4400-4F1C-B04E-F170B4AA7EA7 Q50193584-70EBC297-F8D7-438F-8820-D50D6A194A3C Q52564691-9C776BAD-F365-4E1C-8146-7EF312FC1114

P2860

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation.

http://www.wikidata.org/entity/Q38854836

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A Summary of the Literature Ev ...... ulants in Atrial Fibrillation.

@en

type

label

A Summary of the Literature Ev ...... ulants in Atrial Fibrillation.

@en

prefLabel

A Summary of the Literature Ev ...... ulants in Atrial Fibrillation.

@en

P1433

Q38854836-0E024807-8880-4E74-9AC6-0FCAC6BE40A2

P1476

Q38854836-94E60C0C-6422-45A4-ADA0-196D0A5982B6

P2093

Q38854836-09996304-C39D-4A83-AB4C-08C805D3F798

Q38854836-24C5E354-91E1-4EB7-84C5-187B7690A7E8

Q38854836-2CC5FF33-84E8-403F-87A1-DFED86213575

P2860

Q38854836-0729766F-DF2B-4835-8353-1CF88B710B90

Q38854836-080C26C3-01EC-45DE-B021-4F85BB671C81

Q38854836-0BDD06CC-8A52-4ABE-9A39-5CAC9D233685

Q38854836-159FC229-AB27-4FE8-BD59-A5E2D218C668

Q38854836-16549131-024E-44FC-B714-BF59A70409E2

Q38854836-1A668B70-6AFE-47F4-9D9B-6D1C96B06B98

Q38854836-2199BA8D-402A-4168-9E81-14A9012FE395

Q38854836-2A9C51AC-396D-4F5C-8ABB-0EF8D36F63EE

Q38854836-366E73BF-25D8-4BB9-902E-85B67D6A85B6

Q38854836-421D7086-DEC9-416F-B90C-37DDB14D67D2

P2888

Q38854836-75EF782B-8ECB-491D-962D-5F79ED500099

P304

Q38854836-DF0EE139-188D-4195-91CD-EB9C91D9502C

P31

Q38854836-2B0E02FF-833C-4F9E-8908-F8BAB4A79AB2

P356

Q38854836-C8CAF4DE-4A97-4210-8105-43D03D75AF61

P433

Q38854836-A3AD2A12-7E10-4008-9B9B-D9F3564F9BA6

P478

Q38854836-6B44A796-ECD4-4B55-B00C-AB903F7D7D06

P50

Q38854836-151A942F-C61B-4E63-8EEC-64A368968680

Q38854836-29E69C21-7983-42D1-AD54-A4D4BA1F50B7

Q38854836-519B5AA4-55C1-471F-96BE-8328961EA7F1

P577

Q38854836-781ADFB7-DBEB-4D82-A6C6-F4BD595C2407

P6179

Q38854836-F233FDC0-C06B-48AB-B005-23B724A7863E

P698

Q38854836-DE10EE87-A21B-4FE3-9B8F-CB54B6463CB3

P921

Q38854836-102FEED1-9C96-4E18-A639-4E416DC1FDBA

P356

S40256-016-0171-6

P1433

American journal of cardiovascular drugs

P1476

A Summary of the Literature Ev ...... gulants in Atrial Fibrillation

@en

P2093

Kehinde O Obamiro

http://www.w3.org/2001/XMLSchema#string

Leanne Chalmers

http://www.w3.org/2001/XMLSchema#string

Luke R E Bereznicki

http://www.w3.org/2001/XMLSchema#string

P2860

Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial

Dabigatran versus warfarin in patients with atrial fibrillation

Adherence to Medication

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Edoxaban versus warfarin in patients with atrial fibrillation

Effect of regimen complexity on patient satisfaction and compliance with warfarin therapy.

Rising rates of hospital admissions for atrial fibrillation.

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

P2888

s40256-016-0171-6

P304

349-363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40256-016-0171-6

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Luke R Bereznicki

Leanne Chalmers

Kehinde O Obamiro

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1040832547

http://www.w3.org/2001/XMLSchema#string

P698

27262433

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation